The lack of effective drug therapy for chronic obstructive pulmonary disease (COPD) has increased the interest in PDE4 inhibition in recent years [5], as PDEs are not only highly expressed in airway epithelial cells, but also in leukocytes and other inflammatory cells, which are involved in the pathogenesis of COPD [3]. Here, PDE4A is linked to chronic obstructive pulmonary disease.